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ABSTRACT  
Objective: The present study was designed to investigate the cardioprotective potential of Galangin on Doxorubicin induced cardiotoxicity in rats.  
Methods: Albino rats used in this experiment were pretreated with vehicle, Galangin (100 & 200µg/kg) and Vit-C (20 mg/kg) for 28 days. On 25th
Results: Doxorubicin treated rats exhibited abnormal ECG pattern followed by significant increase in CK-MB, LDH, SGOT, SGPT and LPO level and 
decrease in GSH, CAT, TT when compared to control rats. Pretreatment with different doses of Galangin and Vit-C significantly reduced the serum 
biomarkers and increased the tissue antioxidant level when compared to Doxorubicin alone treated groups. Moreover, pretreatment also improved 
Doxorubicin induced changes in ECG pattern and histopathology of heart.  
 
day, a single dose of Doxorubicin (10 mg/kg, i. p) was administered to groups. After 72 h of Doxorubicin administration, ECG, serum and tissues 
biomarkers were evaluated. Histopathological examination of the heart was performed.  
Conclusion: We conclude that the present study provides experimental evidence that Galangin has strong antioxidant activity, and it can maintain 
cell membrane integrity, and ameliorate oxidative stress induced by high-dose of Doxorubicin administration. These findings might be helpful to 
understand the beneficial effects of Galangin against myocardial injury although further study is needed to confirm its mechanism. 
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INTRODUCTION 
Among the many health predictions for the new millennium, the 
most alarming is that of cardiovascular disease (CVD), heart diseases 
and stroke topping the list for death and disability [1]. The major 
risk factors associated with CHD and stroke are tobacco and alcohol 
abuse, high blood pressure (hypertension), high cholesterol, obesity, 
physical inactivity, and unhealthy diets contributing to high 
prevalence across the world [2]. 
It is well known that cardiovascular diseases are directly or indirectly 
related to oxidative damage that shares a common mechanism of 
molecular and cellular damage [3]. A number of medicinal plants have 
been evaluated for cardiovascular disorder in India and various parts 
of the world using cardio toxic models. Doxorubicin (DOX) induced 
cardiotoxicity are well known standard models to study the beneficial 
effect of many drugs on cardiac dysfunction.  
Current projections suggest that by 
the year 2020 India will have the largest CVD burden in the world. 
One fifth of the deaths in India are from CHD. By the year 2020, it 
will account for one third of all deaths. Sadly, many of these Indians 
will be dying young. Heart disease in India occurs 10 to 15 years 
earlier than in the West [1].  
Recent studies have postulated the involvement of oxygen free 
radicals in the development of cardiomyopathy due to DOX [4,5]. 
Because of the presence of a semiquinone in the tetracyclic aglycone 
molecule of DOX, the drug is reported to increase oxygen free radical 
activity as well as induces the peroxidation of unsaturated lipids 
within the membranes [6]. Moreover, the heart and kidneys are 
highly susceptible to free radical injury, because they contains less 
free radical detoxifying substances (SOD, GSH and CAT) [7]. Overall, 
the free radical hypothesis is the most accepted one and has been 
well documented.  
Galangin (3,5,7-trihydroxy-2-phenylchromen-4-one) is a flavone, a 
type of flavonoids. It is found in high concentrations in Alpinia 
officinarum (lesser galangal) [8] and Helichrysum aureonitens. It is 
also found in the galangal rhizome (Alpinia galanga) 
 
and in Propolis 
[9]. Flavonoids subclasses flavones like Galangin may protect against 
DOX induced toxicities in heart [10]. Antioxidants such as vitamin E, 
vitamin C, vitamin A, coenzyme Q and flavonoids have reported to 
protect against DOX induced cardiotoxicity [11]. 
 
However, to the best of our knowledge, Galangin's protection against 
DOX induced cardiac damage has not yet been reported. Therefore, 
the current study was aimed to investigate the protective effect of 
Galangin against DOX induced cardio toxicity 
MATERIALS AND METHODS 
Drugs and Chemicals  
Estimation of biochemical markers were done by using commercial 
kits. The kits for estimation of serum levels of Creatine Kinase - 
Myocardial band (CK-MB), Lactate Dehydrogenase (LDH), Serum 
Glutamic-Pyruvic Transaminase (SGPT), Serum Glutamic Oxaloacetic 
Transaminase (SGOT) were procured from Erba chemicals and Life 
Diagnostics. Doxorubicin hydrochloride injection (ADRIM 50mg/25 
ml) was purchased from local hospital pharmacy. Remaining all 
other chemicals and reagents used were of analytical grade.  
Animals 
Male wistar rats weighing 150-200g were used. Animals were 
maintained under standard laboratory conditions at 25 ± 20C, 
relative humidity 50 ± 15% and normal photoperiod (12 h dark/ 12 
h light). After seven days of acclimatization period, they were 
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randomly selected into experimental groups. They were given free 
access to food and water ad libitum. 
Groups 
The male wistar rats were divided into 6 groups and each group 
contains 6 rats. Galangin was dissolved in water and administered to 
rats orally using an intra-gastric tube daily. Dose of Galangin 100, 
200µg/kg body weight was selected [12]. All the rats in normal 
control (Group I) group were treated with vehicle and (Group II) 
were treated with 200µg/kg of Galangin alone. All the rats in the 
diseased control (Group III) group were treated single dose DOX 10 
mg/kg, i. p [13], injected to rats on 25th day. The (Group IV & V) 
pretreated with Galangin 100 & 200µg/kg dose and (Group VI) with 
Vit-C 20 mg/kg [14], as standard for 28 days. After pre treatment 
period single dose DOX 10 mg/kg, i. p, injected to rats on 25th
After completion of the treatment, under light ether anesthesia, 
orbital blood samples were obtained using heparinized micro 
capillaries for the estimation of biomarkers. The collected blood was 
allowed to stand for 45 minutes. The clot that was formed was 
disturbed by using a glass rod and was then centrifuged at 4000 rpm 
for 15 min. The serum was separated and used for the analysis. 
 day. 
After 72 h the rats was anaesthetized and the electrocardiograph were 
recorded using computerized data acquisition system (Biopac MP 36, 
Santa Barbara, California). By retro orbital blood samples were 
obtained and used for the estimation serum biomarkers (SGOT, SGPT, 
LDH and CK-MB). Later the animal is subjected to decapitation and 
heart specimen was collected and used for biochemical estimations 
(CAT, TT, GSH, LPO & TP) and histological observation.  
Acute toxicity studies  
The experimental protocol has been approved by the Institutional 
Animal Ethics Committee (Regd. No. 419/01/c/CPCSEA). Acute 
toxicity studies were carried out as per OECD guidelines by 
employing the Up and Down method prior to evaluation of 
cardioprotective activity. 
Dose Selection and experimental induction of myocardial 
toxicity or cardiac stress 
Dose of Doxorubicin was chosen based on preliminary and previous 
studies. In this study commercially available Doxorubicin was used for 
the experimental induction of myocardial toxicity or cardiac stress.  
Assessment of Cardioprotective activity 
Serum analysis 
Isolation of Heart 
The rats were sacrificed by decapitation. The thoracic cavity was 
opened by midline incision, and the hearts were excised. Hearts 
were immediately washed with ice cold 0.1 M sodium phosphate 
buffer (pH 7.4) and placed on blotting paper for a few seconds to 
absorb excess washing solution and were used for the estimation of 
oxidative parameters. 
Biochemical parameters 
Serum samples and heart homogenates were used to estimate CK-
MB, LDH, SGPT, SGOT, LDH, Catalase (CAT), Reduced Glutathione 
(GSH), Malondialdehyde (MDA), Total Thiol (TT).  
Statistical analysis 
The results were expressed as the mean ± S. E. M. The results 
obtained were analyzed using one way ANOVA followed by Tukey's 
post hoc test. Data obtained was computed for statistical analysis 
using software Graph Pad Prism.  
RESULTS 
Effect of Galangin on ECG parameters 
The figure-1, depicts that the electrocardiographic pattern of normal 
control and experimental animals. Normal control and higher dose 
of Galangin (200µg/kg) alone treated rats showed a normal ECG 
pattern, whereas animals treated with DOX alone showed significant 
elevation in ST segment, prolongation in P wave, QRS complex and 
R-R interval. In addition there was a decrease in heart rate, cardiac 
cycles and prolongation of QT interval as compared to normal 
control rats. Pretreatment of Galangin (100 & 200µg/kg) and Vit-C 
(20 mg/kg) for 28 days to DOX treated rats exhibited near to normal 
ECG pattern with a slight elevation in ST segment. Furthermore, 
treatment also resulted in significant (p<0.001) increase in P wave, 
QRS complex and R-R interval, whereas heart rate, QT interval and 
cardiac cycle were maintained near to normal values. 
  
 
Fig. 1: Effect of Galangin on Electrocardiographic patter on DOX - induced cardio toxicity in rats 
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Fig. 2: Effect of Galangin in CK-MB, LDH, SGOT, SGPT on DOX - Cardio toxicity in rats. Each bar represent the Mean ± SEM (n=6), **p<0.001; 
***p<0.001; compared with DOX alone rats. ***p<0.001 compared with normal control. One-way ANOVA followed by Turkeys* post test 
 
 
Fig. 3: Effect of Galangin in CAT, GSH, LPO, TT on DOX - Cardio toxicity in rats. Each bar represent the Mean ± SEM (n=6), *p<0.05; 




Effect of Galangin on serum enzyme markers 
It is observed from figure-2, that the rats administered with DOX (10 
mg/kg) shows a significantly increase in the levels of CK-MB, LDH, 
SGPT and SGOT as compared to Normal rats, Rats pretreated with 
Galangin (200µg/kg) does not showed significant change in the 
enzyme levels as compared with the Normal control rats, pretreated 
with different doses of Galangin (100 or 200µg/kg) or Vit-C(20 
mg/kg) to DOX injected rats shows significant decrease (p < 0.001) 
in the level of CK-MB, LDH, SGPT and SGOT as compared to DOX 
alone treated group. 
Effect of Galangin on Oxidative stress biomarkers 
Reduced Glutathione, Catalase & Total Thiol  
It is observed from figure-3, that the GSH, CAT and TT level in the 
DOX alone treated rats were significantly (p<0.001) decreased, 
when compared with the normal control rats. There levels in 
pretreated with Galangin (100 & 200µg/kg) and vit-C in DOX treated 
groups, were increased significantly (p<0.001) when compared to 
DOX alone group. Whereas GSH, CAT and TT level in Galangin alone 
treated rats did not modify. 
Lipid Peroxidation (LPO)  
It is observed from figure-3, that the TBARS level in the DOX alone 
treated rats were significantly (p<0.001) increased compared with 
the normal control rats. The TBARS level in pretreated with Galangin 
(100 &200µg/kg) Vit-C in DOX treated groups, were decreased 
significantly (p<0.01; p<0.001; p< 0.001, respectively) when 
compared to DOX alone group. There was no significant change in 
TBRS level in Galangin alone treated rats.  
Histopathological changes on DOX-induced cardio toxicity 
Histopathological examination of myocardial tissue as shown in 
figure-4, indicates that the normal control animals exhibited clear 
integrity of myocardial membrane. Control rats showed normal 
cardiac fibers without any infarction. The heart sections obtained 
from DOX treated animals showed abundant areas of necrosis and 
aggregation of acute inflammatory cells and damaged vascular 
spaces. Animals pretreated with Galangin 100µg/kg showed 
improvement in the cell integrity evidenced by decreased necrotic 
area and reduction in infiltration of inflammatory cells. The extent of 
necrosis was approximately 50% in DOX alone treated animals, 
which was decreased to 20% by Galangin 100µg/kg pretreatment. 
The Galangin 200µg/kg pretreatment showed a better protection 
against DOX toxicity evidenced by marked reduction of necrosis and 
marked decrease in infiltration of inflammatory cells and 
maintenance of normal integrity of the cardiac muscles. The animals 
treated with Vit C showed marked reversal of DOX induced 
Histopathological changes. However, Galangin 200µg/kg alone 
treated animals exhibited mild inflammation. 
 
 
Fig. 4: Effect of Galangin: Histopathological study of heart in different groups in DOX - induced Cardio toxicity in rats 
 
DISCUSSION 
In the present study, we found that Galangin exerted a strong cardio 
protective effect against DOX-induced myocardial necrosis in rats. 
Myocardium contains an abundant amount of diagnostic marker 
enzymes for MI and once metabolically damaged, it releases its 
intracellular contents into the extracellular fluid [15]. Hence, the 
serum levels of these marker enzymes reflect the alterations in 
membrane integrity and/or permeability. Cytosolic enzymes CK-MB, 
LDH, SGOT and SGPT which serve as the diagnostic markers, leak out 
from the damaged tissue to the blood stream when cell membrane 
becomes permeable or ruptured [16,17]. DOX administration to rats 
showed elevated levels of serum CK-MB [18], 
It has been reported that infarction of as little as 10% of the total 
myocardium produces a significant rise in the serum levels of SGOT 
and is linear with the amount of infarction [20].
which was found to be 
significantly low in the Galangin pretreated rats. Lactate 
dehydrogenase (LDH) rises within 24-48 hours after a heart attack 
and peaks in two to three days in the serum [19]. Consistent with the 
above clinical observations, in the present study we observed a 
significant rise in the LDH levels of rats treated with DOX after 48 or 
72 h of the respective treatment. Galangin pretreatment significantly 
reduced the elevated levels of LDH indicating the reduction in the 
severity of MI.  
 DOX treatment 
elevated these enzyme levels in serum to a significant extent. 
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Pretreatment with Galangin (100 & 200µg/kg) or Vit-C (20mg/kg) 
significantly lowered the DOX-induced elevation of serum levels of 
these diagnostic marker enzymes. It demonstrates that Galangin 
could maintain membrane integrity thereby restricting the leakage 
of these enzymes as that of Vit-C. 
Administration of supra maximal doses of DOX had been reported to 
induce severe oxidative stress and impair the myocardial 
function.[21, 22] Over production of ROS can cause severe 
impairment of cellular functions and necrotic lesions in the 
myocardium of rats. On the other hand CAT, TT, GSH constitute a 
mutually supportive defense team against oxidative injury.[23] 
As described earlier, increase in MDA level was observed in the 
heart tissues after DOX administration. Malondialdehyde is a major 
lipid per-oxidant end product; the increased level of MDA indicates 
activation of the lipid per-oxidative process, resulting in irreversible 
damage to hearts of animals subjected to DOX stress [13,14. 23]. The 
results presented in this study indicated that pretreatment with 
Galangin (100 or 200µg/kg) could inhibit DOX induced elevation of 
MDA content as that of Vit-C. 
The ECG is considered the single most important initial clinical test 
for diagnosis of myocardial ischemia and infarction. The DOX 
administration significantly increased ST and QT interval while the 
heart rate was significantly decreased as compared to control rats. 
The pretreatment with Galangin in DOX treated rats prevented the 
pathological alterations in the ECG suggestive of its cell membrane 
protective effect in the dose dependant manner as that as Vit-C. 
The results of the serum, tissue biomarkers and ECG were well 
correlated with the Histopathological changes in the heart of disease 
and treatment groups. The myocardial tissue in control rats 
illustrated clear integrity of the myocardial cell membrane and 
absence of inflammatory cell infiltration. DOX injected rats showed 
coagulative necrosis, separation of cardiac muscle fibers and 
infiltration of inflammatory cells. The reduced inflammatory cell 
infiltration and normal cardiac muscle fiber architecture in Galangin 
treated rats further confirmed the cardio protective effect. 
Augmentation of endogenous antioxidants, maintenance of the 
myocardial antioxidant status and significant restoration of most of 
the altered hemodynamic parameters may contribute to Galangin's 
cardio protective effect. 
CONCLUSION 
We conclude that the present study provides experimental evidence 
that Galangin has strong antioxidant activity, and it can maintain cell 
membrane integrity, ameliorate oxidative stress and improve 
cardiac systolic/diastolic dysfunction induced by high-dose DOX 
administration. These findings might be helpful to understand the 
beneficial effects of Galangin against myocardial injury although 
further study is needed to confirm its mechanism. 
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